Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02549833
Title Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications

high grade glioma

malignant astrocytoma

oligodendroglioma

Therapies

GBM6-AD lysate protein vaccine + Poly ICLC

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.